Olefins and methods for making the same
AssigneeAmyris, Inc.
InventorsNicholas Ohler, Karl Fisher, Jin Ki Hong
Life of this patent
Estimating the term…
Abstract
Provided herein are olefinic feedstocks derived from conjugated hydrocarbon terpenes (e.g., C10-C50 terpenes), methods for making the same, and methods for their use.
Claims97
A compound of Formula (I)
- or a tautomer thereof, or a pharmaceutically acceptable salt thereof, wherein
- Z1 is CH or nitrogen;
- Z2 is CH or nitrogen;
- R1 is —CF3 or cyclopropyl;
- R2 is —CF3 or cyclopropyl;
- R3 is hydrogen, C1-C2 alkyl, or C1-C2 haloalkyl;
- R4 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, 4- to 8-membered heterocyclyl, or C3-C6 cycloalkyl,
- wherein the heterocyclyl or cycloalkyl groups are optionally substituted by one to five R6 groups;
- or R3 and R4 are taken together with the carbon atom to which they are attached to form a C3-C5 cycloalkyl or 4- to 6-membered heterocyclyl, each of which is optionally substituted by one to five R6 groups;
- R5 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, or C3-C6 cycloalkyl;
- each R6 is independently C1-C6 alkyl, halo, hydroxy, —O(C1-C6 alkyl), —CN, C1-C6 alkyl-CN, C1-C6 alkyl-OH, or C1-C6 haloalkyl;
- or two R6 groups attached to the same carbon atom are taken together with the carbon atom to which they are attached to form a spiro C3-C6 cycloalkyl or spiro 4- to 6-membered heterocyclyl;
- X is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkyl-OH, C1-C6 alkyl-CN, C3-C6 cycloalkyl optionally substituted by one to five R8 groups, or
- is 4- to 7-membered heterocyclyl or 5- to 8-membered heteroaryl, wherein each heterocyclyl or heteroaryl optionally contains one to two additional heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, and wherein each heterocyclyl or heteroaryl is optionally substituted by one to five R8 groups;
- each R7 is independently hydrogen, C1-C6 alkyl, C1-C6 alkyl-OH, or C1-C6 haloalkyl;
- or two R7 groups are taken together with the carbon atom to which they are attached to form a C3-C5 cycloalkyl or 3- to 5-membered heterocyclyl;
- and
- each R8 is independently halo, C1-C6 alkyl, C1-C6 alkyl-CN, C1-C6 alkyl-OH, C1-C6 haloalkyl, —CN, oxo, or —O(C1-C6 alkyl);
- or two R8 groups are taken together with the carbon atom or atoms to which they are attached to form a spiro or fused C3-C5 cycloalkyl or 3- to 5-membered heterocyclyl.
(canceled)
-50. (canceled)
-62. (canceled)
-80. (canceled)
A composition comprising a cell population containing the modified immune cell of claim 62.
-86. (canceled)
(canceled)
-93. (canceled)
-99. (canceled)
-107. (canceled)
-122. (canceled)
-127. (canceled)
(canceled)
(canceled)
(canceled)
-136. (canceled)
(canceled)
(canceled)
-145. (canceled)
-166. (canceled)
-175. (canceled)
-181. (canceled)
(canceled)
-190. (canceled)
(canceled)
-205. (canceled)
-222. (canceled)
A method of treating cancer, the method comprising
- administering to an individual with cancer an effective amount of an agent capable of lowering activation threshold of an immune cell, and
- administering to the individual an effective amount of a therapeutic cancer vaccine;
- or
- administering to the individual an effective amount of an oncolytic virus.
-226. (canceled)
-237. (canceled)
-254. (canceled)
Dependencies are inferred from the claim text.